A collection of philanthropists, Silicon Valley titans, and Democratic megadonors are using their deep pockets to will Vice ...

As Novo Holdings hopes to close its $16.5 billion acquisition of CDMO Catalent by the end of the year, the deal is facing a fresh round of lawmaker scrutiny. | In a letter to the chair of the U.S.

Pharmacy benefit managers harm the prescription-drug market.

Federal Trade Commission Chair Lina Khan's term as a member of the commission technically expires on Sept. 25. This does not ...

Bloomberg's Max Chafkin breaks down the polarizing role of Federal Trade Commission Chair Lina Khan, whose antitrust campaign has drawn support from progressives as well as some populist-minded ...

The Biden administration is advancing its campaign to promote labor unions through joint actions of federal agencies with a ...

Sen. Elizabeth Warren urges FTC to scrutinize Novo Nordisk's $16.5 billion acquisition of Catalent over concerns of increased ...

Attorneys argue Khan and two other commissioners are biased against pharmacy benefit managers and should recuse themselves from an ongoing lawsuit against the middlemen.

Understand every aspect of the global economy – and know how to make your next move.

Pfizer shared that the combination of its drugs Talzenna and Xtandi extended survival in men with metastatic ...

Alexandria Ocasio-Cortez has threatened a full-out war if Vice President Kamala Harris replaces the head of the Federal Trade Commission.

Senate Democrat Elizabeth Warren urges the Federal Trade Commission to closely scrutinize a proposed merger between Novo Nordisk and contract development and manufacturing organization Catalent, ...